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Symptoms of Menopause
Shaikh Zinnat Ara Nasreen
Abstract
Menopause occurs when a woman stops menstruation permanently at the end 
of the reproductive life. It usually begins around the ages of 45 and 53, median age 
is 51. Many women experience menstrual irregularities soon before it stops. The 
common symptoms of menopause are that women (75%) experience vasomotor 
symptoms, including hot flashes, night sweats, and flushing. Headache, palpitation, 
and tiredness are common. Genitourinary syndrome of menopause (GSM) includes 
dryness of the vagina or vulvovaginal atrophy which causes sore, itching, and 
burning in the vagina and severe dyspareunia. Also it includes urgency, frequency, 
nocturia, repeated UTI, and sexual dysfunction. Mood changes like irritability, 
lack of concentration, loneliness, forgetfulness, insomnia, anxiety, and depression 
bother many women. Joint and muscle pain, backache, osteoporosis, and fracture 
are common. Midsection weight gain, hirsutism, hair fall, and loss of elasticity of 
skin are distressing symptoms. Diminished cognitive capacity, memory loss, and 
dementia are associated with aging, but women with premature ovarian insuffi-
ciency may experience such condition.
Keywords: vasomotor symptoms, hot flashes, VVA, GSM, osteoporosis,  
mood changes
1. Introduction to menopause
Menopause is a normal physiological and natural event. The WHO defined 
menopause as permanent cessation of menstruation due to loss of ovarian 
follicular activities at the end of reproductive life. Menopause before the 
age of 40 years is considered as premature menopause or premature ovarian 
insufficiency.
The average age of menopause is 51 years, which is influenced by both genetic 
and environmental factors. Due to increased life expectancy of women, postmeno-
pausal years cover more than one third of the total female life span.
Though natural events of estrogen deficiency of menopause herald a variety 
of potential problems that can affect the quality of life, specific concerns include 
subjective symptoms such as vasomotor instability, i.e., hot flushes, psycho-
logical and psychomotor disorders, menstrual irregularities, vaginal dryness, 
genitourinary dysfunction, and osteoporosis which have implications for long-
term health [1–6].
So doctors and menopausal women both are interested in and deserve an under-
standing of the symptoms and the basis for therapeutic recommendation aimed at 
relieving symptoms and reducing subsequent health risks.
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2. Definition
Natural menopause is recognized to have occurred after 12 consecutive months 
of amenorrhea, for which there is no other obvious pathological or physiological 
cause. Menopause occurs with the final menstrual period, which is known with 
certainty only in retrospect a year or more after the event. An adequate independent 
biological marker for the event does not exist.
The term “perimenopause” should include the time immediately prior to the 
menopause (when the endocrinological, biological, and clinical features approach-
ing menopause commence) and the first year after menopause.
The term “menopausal transition” should be reserved for the time before the 
final menstrual period when variability in the menstrual cycle is usually increased. 
This term can be used synonymously with “premenopausal.”
Relationship between different time periods surrounding the menopause (modi-
fied from the WHO 96238) is shown in the table below.
FMP
3. Symptoms of menopause
3.1 Menstrual irregularities
Menstrual irregularities are a common complaint during menopause transition. 
Infrequent ovulation and anovulation lead to changes in the length of proliferative 
phase, and in the absence of progesterone, decline of estrogen leads to heavier and 
irregular menstruation. In some women scanty periods with long cycles may be 
the main symptom. The changes of bleeding pattern due to hormonal fluctuation 
usually occurs during perimenopause. The analysuisreported median age at incep-
tion of perimenopause is 47.5 years and smokers have not only early but a shorter 
perimenopause [2]. However, postcoital bleeding, prolonged bleeding, and post-
menopausal bleeding require further investigation.
3.2 Vasomotor symptoms
Vasomotor symptoms are the main bothering and common symptoms in the early 
menopause. They include hot flushes, night sweats, and palpitation and are termed vaso-
motor symptoms because of vascular reactivity with initial prominent vasodilatation. 
Stages −5 to –4 −3 −2 −T″ +1 +2
Terminology Reproductive Menopausal 
transition
Post Menopause
Early peak Late Early Late Early late
Perimenopause
Duration of stage variable Variable l year 4 years 
demise
Until
Menstrual 
cycles
Variable to 
regular
Regular Variable cycle 
length > 7 days 
different from 
normal
>2 skipped 
cycles and an 
interval of 
amenorrhea
12 months 
amenorrhea
None
Endocrine Normal FSH ↑ FSH ↑ FSH FSH
Stages of reproductive aging workshop (STRAW) system.
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Hot flushes are transient periods of intense heat in the upper part of the body usually 
accompanied by sweating. Its exact mechanism is not known, but is believed to be due 
to narrowing of thermoregulatory zone of the hypothalamus with decline of estrogen 
level. Hot flushes and night sweats are experienced by about 40% in early transition, 
increasing to 60–80% in late menopausal women [3]. About 25% can be severe to cause 
significant distress. Sleep disturbances caused by hot flushes and sweating can lead to 
lethargy, poor physical functioning, and depressed mood. In about 25% of women, hot 
flushes may continue for over 5 years; in a small percentage of women, it may continue 
up to 10 years or more. In surgical menopause, vasomotor symptoms are abrupt and 
severe. Low body weight, lack of exercise, and smoking are risk factors for hot flushes.
Severity, frequency, and duration of hot flushes vary with menopausal status, 
ethnicity, age, cultural factors, and woman’s perception of menopause. In many 
western countries and Australia, 60–80% of women experience hot flushes, while 
the prevalence is 20–30% in Chinese and Japanese women. In Asia 40–60% of 
women have hot flushes. Hot flushes have a negative impact on quality of life as 
well as an association with adverse morbid conditions like cardiovascular disease, 
osteoporosis, fragility fractures, and diabetes [4].
3.3 Mood disorders
Mood swings, anxiety, and depression are some of the psychological symptoms 
during menopausal change. Nearly half of women on menopause transition can 
get easily irritated. They become less patient with the members of the family, 
friends, and colleagues and often feel tired and sad. With emotional changes, they 
can appear nervous, stressful, and sometimes aggressive. Mood swings are due to 
changes in serotonin activity following estrogen decline but may also be caused by 
other menopausal symptoms as hot flushes and night sweats.
Anxiety in the form of nervousness, worry, or panic attacks may occur during 
perimenopause. Hormonal changes, vasomotor symptoms, and midlife stresses 
contribute to anxiety during this period. Panic disorders are associated with nega-
tive life events, impairment of activity, or physical illnesses.
Depression is more common in the menopause transition and early postmeno-
pause than premenopausal. A number of reports indicate that there is a significant 
increased risk of new-onset depression in women during menopause [5]. Those who 
had previous episodes of depression are at a higher risk. Depression is associated 
with hormonal changes during this period, stressful life events, poor sleep, hot 
flushes, employment status, ethnicity, and cultural attitudes.
Insomnia may be seen in some women, and they are more likely to have anxiety, 
stress, and depressive disorders. Sleep disorders are associated with menopause 
transition and also related to hot flushes, other physical health problems, psychoso-
cial problems, and medication. Sleep apnea too may occur during this period, and 
obese women are at a higher risk.
3.4 Genitourinary symptoms
Estrogen receptors are present abundantly in the vagina, vestibule, and trigone 
area of the bladder. With estrogen deficiency after menopause, many anatomical 
and physiological changes occur in this area, which results in GSM. Genitourinary 
syndrome of menopause (GSM) is the new term for vulvovaginal atrophy (VVA). 
In 2012, the International Society for the study of Women’s Sexual Health and the 
North American Menopause Society introduced genitourinary syndrome of meno-
pause as a more accurate, comprehensive, and publicly acceptable term to replace 
atrophy or atrophic vaginitis. The Society considered “atrophy” to be a negative 
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term, which suggests “wasting away” and that vaginitis imply an infective or 
inflammatory condition. Neither the old terms encompass the urological symptoms. 
Furthermore, “vagina” was not regarded as a socially acceptable enough word to use 
in public discourse or the media (Maturitas 2014; 79–349).
Due to menopause, the withdrawal of estrogen causes dryness of the vagina, loss 
of elasticity and flexibility of the vagina, and damage of the vaginal epithelium. So 
women complain of the following:
Vaginal dryness or lack of lubrication
Dyspareunia
Postcoital soreness and bleeding (Maturitas 2014; 79–349)
Vulval/vaginal itching, soreness, burning, and discomfort
Urinary frequency, urgency, nocturia, and recurrent UTIs
Urge incontinence
On examination the vagina seems short and narrow, with the absence of rouge, 
and appears pale. About 20–30% of postmenopausal women have urgency and have 
urinary incontinence. With genital prolapse, women may suffer from recurrent 
urinary tract infections.
This dryness of the vagina causes decreased lubrication and sexual dysfunction 
[6]. The single entity of dyspareunia affects all that domains of sexual function. 
If not treated timely, women complain severe sexual dysfunction, which totally 
disrupt the conjugal life.
3.5 Osteoporosis
Accelerated osteoclastic activity and reduced osteoblastic activity and calcitonin 
activity due to reduced estrogen and aging process lead to osteoporosis. Osteoporosis 
is a systemic skeletal disease characterized by low bone mass and micro architectural 
deterioration of bone tissue leading to enhanced bone fragility and a consequent 
increase in fracture risk. Osteoporotic fracture burden is increasing worldwide. About 
half of women 50 and older will have an osteoporosis-related fracture in their life-
time. During the menopausal transition period, the average reduction in bone mass 
density (BMD) is about 10%. Approximately half of women are losing bone even 
more rapidly, perhaps as much as 10–20% in those 5–6 years around menopause.
Women could be asymptomatic, or they might have persistent unexplained back 
pain, recurrent fractures, fracture from minimal trauma, loss of height, and spinal 
deformities. The incidence of fractures increases, particularly of the distal radius, 
vertebral body, and upper femur beyond menopause. Wedge compression frac-
tures of the spine lead to backache. Women complaining chronic back pain, bone 
pain, joint pain, and muscle pain must consult a doctor to exclude osteoporosis. 
Maintaining optimum body weight and avoiding sedentary work, bone toxic agents, 
too much alcohol, and smoking are the key strategies to prevent osteoporosis.
3.6 Cardiovascular disease
With the loss of cardioprotective action of estrogen by its action on lipids, 
endothelial function, and anti-inflammatory effect, menopausal women are more 
liable to get ischemic heart disease. Symptoms of coronary heart disease (CHD) in 
women are somewhat different from typical male type of angina, which are usually 
brought by exertion and relieved by rest. Women with myocardial infarction have 
atypical symptoms like fatigue, shortness of breath, and atypical chest pain. Many 
may have nonobstructive coronary heart disease (CHD); angiogram may not show 
typical obstruction in the coronary arteries. CHD is the commonest cause of death 
among postmenopausal women; the ratio of CHD in men to women becomes 1:1 
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after menopause. The SWAN study suggested that the protective effects of HDL 
might decrease during menopause [7].
3.7 Obesity
Menopause along with aging process is associated with an increased risk of 
obesity and a shift to an abdominal fat distribution with associated increase in 
health risks. Changes in body composition at menopause may be caused by the 
decrease in circulating estrogen. For fat distribution shifts, the relative increase 
in the androgen-estrogen ratio is likely to be important. Large majority of these 
women have an increased body mass index and waist circumference. Midsection fat 
distribution is pronounced during menopause and beyond. Women gaining weight 
especially with increased abdominal girth are prone to develop metabolic syndrome 
and cardiovascular disease.
But weight gain during midlife and beyond is just not due to menopausal 
status [8]. So women must try to maintain the optimum body weight.
3.8 Skin changes
Dry skin and wrinkling are due to the loss of subcutaneous fat and changes in 
composition of connective tissue. Dry hair and hair loss and increased facial hair are 
caused by reduction in estrogen and relative increase in male hormones. Skin becomes 
less elastic and wrinkling appears. Nails become brittle and nail growth becomes slow.
3.9 Joints
Osteoarthritis is commoner in females after menopause, and many epidemio-
logical and clinical studies indicate estrogen deficiency as one of the etiological 
factors in addition to familial tendency, obesity, and aging. In menopausal women, 
the knees and hands are mostly affected.
3.10 Sarcopenia
Menopausal transition is associated with accelerated loss of fat-free mass, a 
decline in resting metabolic rate, and increased central body fatness. The causes of 
sarcopenia or loss of muscle mass are due to hormonal changes at menopause, low 
levels of physical activity, reduced protein intake, and increased oxidative stress.
3.11 Eyes
Postmenopausal women are at a higher risk of developing age-related macular 
degeneration, and association with estrogen deficiency has been suggested.
3.12 Teeth
In the menopausal woman, osteoporosis may lead to loss of the alveolar bone 
of the jaws, resulting in periodontal disease, loose teeth, and tooth loss. Estrogen 
therapy has been shown to increase the alveolar bone mass.
3.13 Memory loss
As estrogen affects cognitive function and neurotransmitters, memory loss has 
been noted at menopause, especially episodic memory and verbal fluency. Estrogen 
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therapy at menopause, whether it reduces the risk of dementia and mild cogni-
tive impairment, is a matter of debate. Women complain of bothersome memory 
symptoms, forgetfulness, and difficulties with word retrieval and brain fog [9].
3.14 Alzheimer disease
Alzheimer’s disease (AD) is more common in postmenopausal women than 
in men of the same age. It is accompanied by progressive cognitive impairment 
and reduces the quality of life of the woman. These women have memory loss and 
confusion and are unable to recognize family members and friends. Often they have 
repetitive statements and movements and may have difficulty in getting up from a 
chair. Aging and other factors along with menopause are responsible, so menopause 
is not the direct cause of AD.
4. Key points
• The diverse symptoms associated with menopause are mainly caused by 
estrogen deficiency.
• Manifestations are seen in different body systems.
• Problems such as vasomotor symptoms, menstrual irregularities, joint pain, 
sarcopenia osteoporosis, and genitourinary disorders are troublesome and 
common.
• Pathologies such as osteoporosis, obesity, coronary heart disease, mood disor-
ders, and memory problems have significant morbidity and mortality.
• Proper identification and timely optimum treatment may prevent the long-
term health risks and ameliorate the symptoms of menopause and improve the 
quality of women’s life.
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